Will 3M Earnings See a Pandemic Boost?

Photo of Chris Lange
By Chris Lange Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Will 3M Earnings See a Pandemic Boost?

© pengpeng / iStock Unreleased via Getty Images

3M Co. (NYSE: MMM | MMM Price Prediction) is scheduled to report its most recent quarterly results before the markets open on Tuesday. Analysts are looking for $2.03 in earnings per share (EPS) and $7.91 billion in revenue for the first quarter. The same period of last year reportedly had EPS of $2.23 on $8.02 billion in revenue.

This company has been a major player in the fight against the coronavirus. In fact, the U.S. enacted the Defense Production Act (DPA) to require 3M to prioritize orders from the Federal Emergency Management Agency (FEMA) for its N95 respirators.

In this collaboration with the current administration, 3M has increased the number of respirators it imports from overseas operations into the United States. Earlier this month, the company secured approval from China to export to the United States 10 million N95 respirators manufactured by 3M in China.

The White House also requested that 3M cease exporting respirators that it currently manufactures in the United States to the Canadian and Latin American markets.

We can look for a further update on this in the coming report on Tuesday morning.

[nativounit]

Excluding Monday’s move, 3M stock had underperformed the S&P 500 and Dow Jones industrial average, with shares down nearly 17% year to date. In the past 52 weeks, the share price was down closer to 23%.

Here’s what a few analysts had to say ahead of the report:

  • Langenberg has a Buy rating with a $180 price target.
  • Deutsche Bank rates it a Hold with a $158 price target.
  • Citigroup has a Neutral rating and a $146 price target.
  • RBC’s Hold rating comes with a $143 target price.
  • Goldman Sachs has a Neutral rating and a $159 target.

3M stock traded up on Monday about 3% to $151.88, in a 52-week range of $114.04 to $192.19. The consensus price target is $146.47.

[recirclink id=684512][wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618